4.6 Review

Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE

期刊

PROGRESS IN LIPID RESEARCH
卷 44, 期 2-3, 页码 154-183

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.plipres.2005.04.002

关键词

5-oxo-ETE; 5-lipoxygenase; leukotrienes; eosinophils; neutrophils; inflammation; eicosanoids; oxidative stress; lipid mediators; chemoattractants

资金

  1. NHLBI NIH HHS [HL69835] Funding Source: Medline
  2. NIDDK NIH HHS [DK44730] Funding Source: Medline

向作者/读者索取更多资源

5-Oxo-ETE (5-oxo-6,8,11,14-eicosatetraenoic acid) is an arachidonic acid metabolite formed by the oxidation of 5S-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE) by 5-hydroxyeicosanoid dehydrogenase (5-HEDH), a microsomal enzyme found in leukocytes and platelets. 5-HEDH is highly selective for 5S-HETE, and displays little activity for other monohydroxy metabolites of arachidonic acid. The synthesis of 5-oxo-ETE requires NADP(+) and can be stimulated by activation of the respiratory burst and by oxidative stress. 5-Oxo-ETE is a chemoattractant for eosinophils and neutrophils, and elicits a variety of responses in these cells, including actin polymerization, calcium mobilization, integrin expression, and degranulation. Its primary target appears to be the eosinophil, and among lipid mediators it is the strongest chemoattractant for these cells. It is also a chemoattractant for monocytes and stimulates the proliferation of prostate tumor cells. Its actions are mediated by a G(i) protein-coupled receptor (OXE receptor) that is highly expressed by eosinophils > neutrophils > monocytes. When administered in vivo in both humans and rodents it elicits tissue eosinophilia, suggesting that it may be an important mediator in allergic diseases such as asthma, and that the development of drugs designed to prevent its formation or effects may be useful therapeutic agents in these diseases. (c) 2005 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据